Evidence map›Paper›PMID 27757551›Full record

ArticleJournal of industrial microbiology & biotechnology2016

FkbN and Tcs7 are pathway-specific regulators of the FK506 biosynthetic gene cluster in Streptomyces tsukubaensis L19.

Xiao-Sheng Zhang, Hong-Dou Luo, Yang Tao, Yue-Yue Wang, Xin-Hang Jiang, Hui Jiang, Yong-Quan Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Onset of Tacrolimus Biosynthesis inAntibiotics (Basel, Switzerland) · 2020
    Article
  9. Article
  10. The Application of Regulatory Cascades inFrontiers in microbiology · 2020
    Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiao-Sheng ZhangCollege of Life Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Hong-Dou LuoCollege of Life Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Yang TaoCollege of Life Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Yue-Yue WangSchool of Life Sciences, Fudan University, Shanghai, 200438, China.
Xin-Hang JiangCollege of Life Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Hui JiangCollege of Life Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China. jianghuisioc@zju.edu.cn.
Yong-Quan LiCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China. lyq@zju.edu.cn.
Zhejiang University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FK506 (tacrolimus), which is produced by many Streptomyces strains, is clinically used as an immunosuppressive agent and for treatment of inflammatory skin diseases. Here, we identified that the FK506 biosynthetic gene cluster in an industrial FK506-producing strain Streptomyces tsukubaensis L19 is organized as eight transcription units. Two pathway-specific regulators, FkbN and Tcs7, involved in FK506 biosynthesis from S. tsukubaensis L19 were characterized in vivo and in vitro. FkbN activates the transcription of six transcription units in FK506 biosynthetic gene cluster, and Tcs7 activates the transcription of fkbN. In addition, the DNA-binding specificity of FkbN was determined. Finally, a high FK506-producing strain was constructed by overexpression of both fkbN and tcs7 in S. tsukubaensis L19, which improved FK506 production by 89 % compared to the parental strain.

Indexed as

Bacterial ProteinsBioreactorsBiosynthetic PathwaysGene Expression Regulation, BacterialImmunosuppressive AgentsMultigene FamilyStreptomycesTacrolimusTrans-ActivatorsBacterial ProteinsImmunosuppressive AgentsTacrolimusTrans-ActivatorsBiosynthesisFK506Regulatory mechanismStreptomyces tsukubaensis

Identifiers

PMID27757551
OpenAlexW2533993509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.